We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$13.6M
Cap. Flow
+$175M
Cap. Flow %
16.88%
Top 10 Hldgs %
6.41%
Holding
1,241
New
361
Increased
285
Reduced
228
Closed
365

Top Buys

Rank Stock Value
1
AEGN
Aegion Corp
AEGN
+$6.95M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$6.17M
3
MTOR
MERITOR, Inc.
MTOR
+$6.08M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$5.62M
5
KRA
Kraton Corporation
KRA
+$5.45M

Top Sells

Rank Stock Value
1
NTUS
Natus Medical Inc
NTUS
+$5.73M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
+$5.45M
3
UNTD
UNITED ONLINE INC COM NEW
UNTD
+$5.41M
4
JIVE
Jive Software, Inc.
JIVE
+$5.4M
5
MMSI icon
Merit Medical Systems
MMSI
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.01%
2 Industrials 14.63%
3 Technology 13.41%
4 Consumer Discretionary 11.65%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFNC icon
1026
Simmons First National
SFNC
$3.35B
– –
-51,420
Closed -$1.2M
SGC icon
1027
Superior Group of Companies
SGC
$196M
– –
-27,924
Closed -$462K
SMCI icon
1028
Super Micro Computer
SMCI
$18.5B
– –
-214,430
Closed -$634K
SRL icon
1029
Scully Royalty
SRL
$78M
– –
-3,567
Closed -$72K
SRI icon
1030
Stoneridge
SRI
$209M
– –
-60,985
Closed -$714K
SSP icon
1031
E.W. Scripps
SSP
$275M
– –
-43,266
Closed -$989K
SUP
1032
DELISTED
Superior Industries International
SUP
– –
-64,280
Closed -$1.18M
TARA icon
1033
Protara Therapeutics
TARA
$228M
– –
-528
Closed -$377K
TBI
1034
Trueblue
TBI
$236M
– –
-33,428
Closed -$999K
TFIN icon
1035
Triumph Financial Inc
TFIN
$1.79B
– –
-34,955
Closed -$460K
THR
1036
DELISTED
Thermon Group Holdings
THR
– –
-74,678
Closed -$1.8M
TIPT icon
1037
Tiptree Inc
TIPT
$679M
– –
-50,977
Closed -$370K
TLYS icon
1038
Tilly's
TLYS
$117M
– –
-20,729
Closed -$200K
TNXP icon
1039
Tonix Pharmaceuticals
TNXP
$163M
– –
0
– -$164K
TOVX icon
1040
Theriva Biologics
TOVX
$9.74M
– –
-6
Closed -$159K
TSE
1041
DELISTED
Trinseo
TSE
– –
-130,394
Closed -$3.5M
TWIN icon
1042
Twin Disc
TWIN
$333M
– –
-18,088
Closed -$337K
TXRH icon
1043
Texas Roadhouse
TXRH
$13.4B
– –
-17,820
Closed -$667K
TYG
1044
Tortoise Energy Infrastructure Corp
TYG
$1.11B
– –
-4,064
Closed -$600K
UPBD icon
1045
Upbound Group
UPBD
$1.21B
– –
-165,453
Closed -$4.69M
UPLD icon
1046
Upland Software
UPLD
$13.3M
– –
-2,350
Closed -$217K
UTL icon
1047
Unitil
UTL
$1.01B
– –
-45,727
Closed -$1.51M
UVV icon
1048
Universal Corp
UVV
$1.36B
– –
-18,174
Closed -$1.04M
VERU icon
1049
Veru
VERU
$36.9M
– –
-1,075
Closed -$19K
VTOL icon
1050
Bristow Group
VTOL
$1.37B
– –
-28,758
Closed -$1.18M
40 41
42
43 44

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q3 2015 Portfolio in Review

As of Q3 2015, TFS Capital held 1,241 positions worth $1.04B, up 1.3% from $1.02B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

TFS Capital deployed $175M of net new capital in Q3 2015, opening 361 new positions and adding to 285 existing holdings. Its largest new stake was Aegion Corp: 384,454 shares worth $6.34M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Merit Medical Systems, an estimated $5.27M trimmed.

  • TFS Capital's largest Q3 2015 buy was Aegion Corp: 384,454 shares worth $6.34M.
  • TFS Capital added most to Pernix Therapeutics Holdings, Inc. in Q3 2015, an estimated $6.17M increase.
  • TFS Capital's biggest Q3 2015 reduction was Merit Medical Systems, cutting an estimated $5.27M.
  • TFS Capital fully exited Natus Medical Inc in Q3 2015, selling an estimated $5.73M.
  • TFS Capital's ten largest holdings make up 6.4% of its $1.04B portfolio in Q3 2015.
  • TFS Capital opened 361 new positions and closed 365 in Q3 2015.
  • TFS Capital's portfolio value rose 1.3% quarter-over-quarter to $1.04B.

Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.